Clinical trial
Efficacy and Safety of Diclofenac Sodium Gel (DSG) in Knee Osteoarthritis
NCT00426621 · Novartis, Industry · Completed
Key facts
| NCT number | NCT00426621 |
|---|---|
| Title | Efficacy and Safety of Diclofenac Sodium Gel (DSG) in Knee Osteoarthritis |
| Official title | A 12-Week, Randomized, Double-Blind, Multi-Center, Vehicle-Controlled, Parallel Group Study to Assess the Efficacy and Safety of the Diclofenac Sodium Gel 1% for the Relief of Signs and Symptoms in Patients With Osteoarthritis of the Knee. |
| Lead sponsor | Novartis, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Osteoarthritis of the Knee |
| Intervention type | Drug |
| Interventions | Diclofenac Sodium Gel, Placebo |
| Enrollment | 420 |
| Start date | Nov 1, 2006 |
| Completion | Jun 1, 2007 |
| First posted | Jan 25, 2007 |
| Last update posted | Dec 18, 2007 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: